| Structure |
Chemical Name |
CAS |
MF |
 |
4'-FLUOROCYCLOPROPANECARBOXANILIDE |
2354-89-4 |
C10H10FNO |
 |
(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid |
102507-85-7 |
C9H11N3O5S |
 |
Cefaclor EP IMpurity |
|
|
 |
Linagliptin Impurity F |
1673546-62-7 |
C27H27F3N8O3 |
|
|
Parecoxib Impurity D |
|
|
|
|
Parecoxib Impurity I |
|
|
 |
Lenvatinib Impurity d |
417717-04-5 |
C20H17ClN4O4 |
 |
4-ブロモ-3-(ヒドロキシメチル)フェノール |
2737-20-4 |
C7H7BrO2 |
 |
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile |
906673-54-9 |
C14H8BrNO2 |
|
|
Linagliptin Impurity I |
|
|
 |
1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
1807642-39-2 |
C16H10FN3O2S |
![4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium](/CAS/20180629/GIF/749821-19-0.gif) |
4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium |
749821-19-0 |
C13H14F2N7O+ |
|
|
Canagliflozin Defluoro Impurity |
|
|
|
|
Dapagliflozin Impurity 6 |
|
|
 |
Imatinib Impurity 7 |
581076-64-4 |
C8H12N4 |
 |
Nilotinib Impurity 1 |
641571-05-3 |
C28H22F3N7O |
|
|
Riociguat Impurtiy 1 |
|
|
 |
Riociguat Impurtiy 6 |
1702271-98-4 |
C18H17FN8 |
 |
Brimonidine Impurity E |
168329-48-4 |
C9H8BrN5 |
|
|
Dapagliflozin Impurity G |
|
|
|
|
Dapoxetine Impurity B |
|
|
 |
Fesoterodine Diol Dimer |
1428856-45-4 |
C44H60N2O3 |
 |
Gimeracil Impurity |
17902-24-8 |
C8H9ClN2O3 |
|
|
Pramipexole Impurity H |
|
|
 |
Rivaroxaban Impurity H |
1807455-76-0 |
C25H24Cl2N4O6S2 |
|
|
Vonoprazan impurity A |
|
|
 |
5-ethyl 3-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
2170716-02-4 |
C22H29ClN2O5 |
|
|
Ibrutinib impurity D |
|
|
 |
Mupirocin impurity A |
|
C26H44O9 |
 |
FG-4592 intermediate7 |
1509958-19-3 |
C20H20N2O4 |
 |
Milnacipran Impurity 13 |
710339-49-4 |
C12H16NO+ |
|
|
Urapidil Impurity A |
|
|
|
|
Tofacitinib Impurity I |
|
|
 |
N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine |
153437-78-6 |
C16H13ClFN3O2 |
![N-[4-[2-(メチルアミノ)エトキシ]ベンジル]-3,4-ジメトキシベンズアミド](/CAS/20200515/GIF/141996-97-6.gif) |
N-[4-[2-(メチルアミノ)エトキシ]ベンジル]-3,4-ジメトキシベンズアミド |
141996-97-6 |
C19H24N2O4 |
 |
Mirabegron Impurity |
1796931-48-0 |
C21H24N4O2S |
 |
34-Methylcyanocobalamin |
38218-51-8 |
C64H90CoN14O14P |
|
|
Empagliflozin Impurity D |
|
|
|
|
Ipragliflozin Impurity 2 |
|
|
|
|
Nicergoline EP impurity F |
|
|
|
|
Mirabegron Impurity 4 |
|
|
 |
Bisoprolol EP Impurity D |
1225195-71-0 |
C26H40N2O5 |
 |
2-(4-イソブトキシフェニル)-4-メチルチアゾール-5-カルボン酸 |
1206550-99-3 |
C15H17NO3S |
![(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one](/CAS/20200119/GIF/14639-79-3.gif) |
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one |
14639-79-3 |
C19H28O |
 |
Cefuroxime Sodium Impurity |
|
C16H16N4NaO8S |
 |
2-Bromo (S)-Carbidopa |
43197-33-7 |
C10H13BrN2O4 |
![1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20200401/GIF/2205053-60-5.gif) |
1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2205053-60-5 |
C21H24FN3O4 |
 |
Brexpiprazole N-Oxide |
1191900-58-9 |
C25H27N3O3S |
 |
2,6-Dibenzyloxyacetophenone |
3886-19-9 |
C22H20O3 |
![6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル](/CAS/20180703/GIF/1059630-08-8.gif) |
6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル |
1059630-08-8 |
C14H17BrN2O2 |
 |
diphenhydramine impurity |
|
C17H21NO |
![1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide](/CAS/20180703/GIF/CB83146796.gif) |
1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
|
C18H23IN4S |
 |
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1657014-33-9 |
C16H16N2O3S |
 |
vildagliptin Impurity O |
2253194-12-4 |
C12H18N4O2 |
![methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-17-9.gif) |
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-17-9 |
C21H26N2O3 |
 |
Canagliflozin Impurity 17 |
1951467-28-9 |
C24H23FO6S |
|
|
Canagliflozin Impurity 22 |
|
|
|
|
Carfilzomib Impurity 3 |
|
|
|
|
Dolutegravir Impurity 4 |
|
|
|
|
Febuxostat Impurity 20 |
|
|
|
|
Lenvatinib Impurity 1 |
|
|
![methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/83508-82-1.gif) |
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
83508-82-1 |
C21H26N2O3 |
![4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester](/CAS/20180703/GIF/1941177-45-2.gif) |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
 |
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
 |
Amlodipine Impurity 19 |
|
C26H31ClN2O8S |
 |
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
 |
Clopidogrel Impurity 7 |
444728-13-6 |
C15H15ClN2OS |
 |
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
 |
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
 |
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
 |
Nilotinib genotoxic impurity 2 |
1157857-29-8 |
C19H15F3N4O3 |
![N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン](/CAS/20180808/GIF/1453221-45-8.gif) |
N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン |
1453221-45-8 |
C35H41F6N3O6 |
|
|
Gliclazide Impurity E |
|
|
 |
Ethyl 1-butanesulfonate |
2374-68-7 |
C6H14O3S |
 |
OLANEXIDINE intermediate |
60852-95-1 |
C10H20N4 |
 |
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
![1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)](/CAS/20180601/GIF/155272-03-0.gif) |
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
 |
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
181289-34-9 |
C9H17NO3 |
![4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate](/CAS/20180601/GIF/65141-48-2.gif) |
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
 |
2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE |
91219-90-8 |
C11H15NO3 |
 |
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
 |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
|
|
Tadalafil EP impurity E |
|
|
![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine](/CAS/20200611/GIF/134965-85-8.gif) |
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
 |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
 |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
![1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one](/CAS/20200401/GIF/220182-11-6.gif) |
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
 |
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
 |
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
 |
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |
 |
phenyl (R)-methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamate |
603996-87-8 |
C8H11NO2S |
|
|
Canagliflozin impurity H |
|
|
 |
Cefazolin Impurity 9 |
1322626-65-2 |
C14H15N9O3S3 |
 |
Dapagliflozin Impurity 20 |
2040305-09-5 |
C29H33ClO10 |
 |
Edaravone Impurity 10 |
710307-89-4 |
C10H12N2O2 |
|
|
Empagliflozin Impurity 23 |
|
|
 |
Entecavir Impurity 3 |
1391053-94-3 |
C12H15N5O4 |
|
|
IBrutinib Impurity C |
|
|
|
|
Imatinib impurity 12 |
|
|
|
|
Isavuconazole Impurity 20 |
|
|